Methotrexate and cyclosporin combined therapy in severe psoriatic arthritis. A pilot study. 1994

G Mazzanti, and L Coloni, and G De Sabbata, and G Paladini
2nd Division of Internal Medicine, Trieste General Hospital, Italy.

UI MeSH Term Description Entries
D008297 Male Males
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015535 Arthritis, Psoriatic A type of inflammatory arthritis associated with PSORIASIS, often involving the axial joints and the peripheral terminal interphalangeal joints. It is characterized by the presence of HLA-B27-associated SPONDYLARTHROPATHY, and the absence of rheumatoid factor. Psoriasis Arthropathica,Psoriasis, Arthritic,Psoriatic Arthritis,Psoriatic Arthropathy,Arthritic Psoriasis,Arthropathies, Psoriatic,Arthropathy, Psoriatic,Psoriatic Arthropathies
D016572 Cyclosporine A cyclic undecapeptide from an extract of soil fungi. It is a powerful immunosupressant with a specific action on T-lymphocytes. It is used for the prophylaxis of graft rejection in organ and tissue transplantation. (From Martindale, The Extra Pharmacopoeia, 30th ed). Cyclosporin A,Ciclosporin,CsA-Neoral,CyA-NOF,Cyclosporin,Cyclosporine A,Neoral,OL 27-400,Sandimmun,Sandimmun Neoral,Sandimmune,CsA Neoral,CsANeoral,CyA NOF,OL 27 400,OL 27400

Related Publications

G Mazzanti, and L Coloni, and G De Sabbata, and G Paladini
February 2006, Clinical therapeutics,
G Mazzanti, and L Coloni, and G De Sabbata, and G Paladini
July 2009, Zhonghua nei ke za zhi,
G Mazzanti, and L Coloni, and G De Sabbata, and G Paladini
May 2000, Journal of the European Academy of Dermatology and Venereology : JEADV,
G Mazzanti, and L Coloni, and G De Sabbata, and G Paladini
January 1983, Acta dermato-venereologica,
G Mazzanti, and L Coloni, and G De Sabbata, and G Paladini
April 1988, British journal of rheumatology,
G Mazzanti, and L Coloni, and G De Sabbata, and G Paladini
January 2005, Terapevticheskii arkhiv,
G Mazzanti, and L Coloni, and G De Sabbata, and G Paladini
January 1994, Acta dermato-venereologica. Supplementum,
G Mazzanti, and L Coloni, and G De Sabbata, and G Paladini
August 1990, Annals of the rheumatic diseases,
G Mazzanti, and L Coloni, and G De Sabbata, and G Paladini
January 1995, Clinical and experimental rheumatology,
G Mazzanti, and L Coloni, and G De Sabbata, and G Paladini
May 2003, Annals of the rheumatic diseases,
Copied contents to your clipboard!